Effectiveness of secukinumab for overlapping hidradenitis suppurativa and ankylosing spondylitis

被引：0
|
作者：
AlAfeefi, Mariam [1 ]
Aladawi, Meera [1 ]
机构：
[1] Sheikh Khalifa Med City, Dept Dermatol, Abu Dhabi, U Arab Emirates
来源：
JEADV CLINICAL PRACTICE | 2024年 / 3卷 / 04期
关键词：
ankylosing spondylitis; biologics; hidradenitis suppurativa; quality of life; secukinumab;
D O I：
10.1002/jvc2.458
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Hidradenitis suppurativa is a chronic inflammatory disease of the hair follicle that affects the axillary and gluteal regions. Hidradenitis can coincide with other inflammatory diseases, such as ankylosing spondylitis. We present a patient suffering from an overlap of both conditions, who had a rapid improvement with secukinumab.
引用
收藏
页码：1274 / 1277
页数：4
相关论文
共 50 条
  • [1] Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever
    Enginar, Ayse Unal
    Gundogdu, Mustafa
    [J]. MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (01) : 19 - 21
  • [2] Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)
    Reguiai, Z.
    Fougerousse, A. C.
    Maccari, F.
    Becherel, P. A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (11) : E750 - E751
  • [3] Secukinumab in the treatment of hidradenitis suppurativa
    Snyder, Corey L.
    Gibson, Ruby S.
    Porter, Martina L.
    Kimball, Alexa B.
    [J]. IMMUNOTHERAPY, 2023, : 1449 - 1457
  • [4] Effectiveness and safety of secukinumab in patients with hidradenitis suppurativa: Our clinical experience
    Melgosa Ramos, Francisco Javier
    Garcia-Ruiz, Ramon
    Sanchez-Martinez, Eva M.
    Gegundez-Hernandez, Hector
    Diaz Corpas, Tania
    Perez Garcia, Pilar
    Ferrando Roca, Francisco Jose
    Zayas Gavila, Ana Isabel
    Mateu-Puchades, Almudena
    [J]. EXPERIMENTAL DERMATOLOGY, 2021, 30 : 79 - 80
  • [5] COST-EFFECTIVENESS OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS IN BRAZIL
    Libanore, A.
    Huerta, C.
    Tozato, C.
    [J]. VALUE IN HEALTH, 2020, 23 : S221 - S221
  • [6] Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
    Emery, Paul
    Van Keep, Marjolijn
    Beard, Steve
    Graham, Chris
    Miles, LaStella
    Jugl, Steffen Marc
    Gunda, Praveen
    Halliday, Anna
    Marzo-Ortega, Helena
    [J]. PHARMACOECONOMICS, 2018, 36 (08) : 1015 - 1027
  • [7] Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
    Paul Emery
    Marjolijn Van Keep
    Steve Beard
    Chris Graham
    LaStella Miles
    Steffen Marc Jugl
    Praveen Gunda
    Anna Halliday
    Helena Marzo-Ortega
    [J]. PharmacoEconomics, 2018, 36 : 1015 - 1027
  • [8] Secukinumab: A Review in Ankylosing Spondylitis
    Hannah A. Blair
    Sohita Dhillon
    [J]. Drugs, 2016, 76 : 1023 - 1030
  • [9] Secukinumab: A Review in Ankylosing Spondylitis
    Blair, Hannah A.
    Dhillon, Sohita
    [J]. DRUGS, 2016, 76 (10) : 1023 - 1030
  • [10] Secukinumab: A Review in Ankylosing Spondylitis
    Blair, Hannah A.
    [J]. DRUGS, 2019, 79 (04) : 433 - 443
12345